The p14 FAST Protein of Reptilian Reovirus Increases Vesicular Stomatitis Virus Neuropathogenesis
- 15 January 2009
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 83 (2), 552-561
- https://doi.org/10.1128/jvi.01921-08
Abstract
The fusogenic orthoreoviruses express nonstructural fusion-associated small transmembrane (FAST) proteins that induce cell-cell fusion and syncytium formation. It has been speculated that the FAST proteins may serve as virulence factors by promoting virus dissemination and increased or altered cytopathology. To directly test this hypothesis, the gene encoding the p14 FAST protein of reptilian reovirus was inserted into the genome of a heterologous virus that does not naturally form syncytia, vesicular stomatitis virus (VSV). Expression of the p14 FAST protein by the VSV/FAST recombinant gave the virus a highly fusogenic phenotype in cell culture. The growth of this recombinant fusogenic VSV strain was unaltered in vitro but was significantly enhanced in vivo. The VSV/FAST recombinant consistently generated higher titers of virus in the brains of BALB/c mice after intranasal or intravenous infection compared to the parental VSV/green fluorescent protein (GFP) strain that expresses GFP in place of p14. The VSV/FAST recombinant also resulted in an increased incidence of hind-limb paralysis, it infected a larger volume of brain tissue, and it induced more extensive neuropathology, thus leading to a lower maximum tolerable dose than that for the VSV/GFP parental virus. In contrast, an interferon-inducing mutant of VSV expressing p14 was still attenuated, indicating that this interferon-inducing phenotype is dominant to the fusogenic properties conveyed by the FAST protein. Based on this evidence, we conclude that the reovirus p14 FAST protein can function as a bona fide virulence factor.Keywords
This publication has 41 references indexed in Scilit:
- A Virus-Encoded Cell–Cell Fusion Machine Dependent on Surrogate AdhesinsPLoS Pathogens, 2008
- Oncolytic Efficacy of Recombinant Vesicular Stomatitis Virus and Myxoma Virus in Experimental Models of Rhabdoid TumorsClinical Cancer Research, 2008
- Induction of strong antitumor immunity by an HSV‐2‐based oncolytic virus in a murine mammary tumor modelThe Journal of Gene Medicine, 2007
- Peripheral, but not central nervous system, type I interferon expression in mice in response to intranasal vesicular stomatitis virus infectionJournal of NeuroVirology, 2007
- Avian reovirus: Structure and biologyVirus Research, 2006
- Extensive Syncytium Formation Mediated by the Reovirus FAST Proteins Triggers Apoptosis-Induced Membrane InstabilityJournal of Virology, 2005
- VSV Disrupts the Rae1/mrnp41 mRNA Nuclear Export PathwayMolecular Cell, 2005
- Vesicular stomatitis virus: re-inventing the bulletTrends in Molecular Medicine, 2004
- Reptilian Reovirus Utilizes a Small Type III Protein with an External Myristylated Amino Terminus To Mediate Cell-Cell FusionJournal of Virology, 2004
- Characterization of a reovirus isolate from a rattle snake,Crotalus viridis, with neurological dysfunctionArchiv für die gesamte Virusforschung, 1994